Evidence map›Paper›PMID 40055432›Full record

ArticleScientific reports2025

Clinical and brain functional correlates of instrumental rigidity measurement in Parkinson's disease.

Yoshikazu Nakano, Shigeki Hirano, Mitsuyoshi Tamura, Yume Koizumi, Yoshihisa Kitayama, Michiko Izumi, Masahide Suzuki, Kosuke Yamagishi, Yutaro Suzuki, Shinobu Ikeda and 9 more

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Yoshikazu NakanoDepartment of Neurology, Chiba University Graduate School of Medicine, 1-8-1, Inohana, Chuo-ku, Chiba, 264-8670, Chiba, Japan.
Shigeki HiranoDepartment of Neurology, Chiba University Graduate School of Medicine, 1-8-1, Inohana, Chuo-ku, Chiba, 264-8670, Chiba, Japan. s_hirano@chiba-u.jp.
Mitsuyoshi TamuraDepartment of Neurology, Chiba University Graduate School of Medicine, 1-8-1, Inohana, Chuo-ku, Chiba, 264-8670, Chiba, Japan.
Yume KoizumiDepartment of Neurology, Chiba University Graduate School of Medicine, 1-8-1, Inohana, Chuo-ku, Chiba, 264-8670, Chiba, Japan.
Yoshihisa KitayamaDepartment of Neurology, Chiba University Graduate School of Medicine, 1-8-1, Inohana, Chuo-ku, Chiba, 264-8670, Chiba, Japan.
Michiko IzumiDepartment of Neurology, Chiba University Graduate School of Medicine, 1-8-1, Inohana, Chuo-ku, Chiba, 264-8670, Chiba, Japan.
Masahide SuzukiDepartment of Neurology, Chiba University Graduate School of Medicine, 1-8-1, Inohana, Chuo-ku, Chiba, 264-8670, Chiba, Japan.
Kosuke YamagishiDepartment of Neurology, Chiba University Graduate School of Medicine, 1-8-1, Inohana, Chuo-ku, Chiba, 264-8670, Chiba, Japan.
Yutaro SuzukiDepartment of Neurology, Chiba University Graduate School of Medicine, 1-8-1, Inohana, Chuo-ku, Chiba, 264-8670, Chiba, Japan.
Shinobu IkedaDivision of Laboratory Medicine, Chiba University Hospital, Chiba, Chiba, Japan.
Ayaka AraseDivision of Laboratory Medicine, Chiba University Hospital, Chiba, Chiba, Japan.
Tatsuya YamamotoDepartment of Neurology, Chiba University Graduate School of Medicine, 1-8-1, Inohana, Chuo-ku, Chiba, 264-8670, Chiba, Japan.
Yoshitaka YamanakaDepartment of Neurology, Chiba University Graduate School of Medicine, 1-8-1, Inohana, Chuo-ku, Chiba, 264-8670, Chiba, Japan.
Atsuhiko SugiyamaDepartment of Neurology, Chiba University Graduate School of Medicine, 1-8-1, Inohana, Chuo-ku, Chiba, 264-8670, Chiba, Japan.
Kazumoto ShibuyaDepartment of Neurology, Chiba University Graduate School of Medicine, 1-8-1, Inohana, Chuo-ku, Chiba, 264-8670, Chiba, Japan.
Takuro HorikoshiDiagnostic Radiology and Radiation Oncology, Chiba University Graduate School of Medicine, Chiba, Chiba, Japan.
Takashi UnoDiagnostic Radiology and Radiation Oncology, Chiba University Graduate School of Medicine, Chiba, Chiba, Japan.
David EidelbergCenter for Neurosciences, The Feinstein Institutes for Medical Research, Manhasset, NY, USA.
Satoshi KuwabaraDepartment of Neurology, Chiba University Graduate School of Medicine, 1-8-1, Inohana, Chuo-ku, Chiba, 264-8670, Chiba, Japan.

Funding

Japanese Society of Neurology Overseas Research Program 2023Japan Society for the Promotion of Science KAKENHI 23K06922Movement Disorders Society of Japan (MDSJ) Overseas Research Program 2024Society of Nuclear Medicine and Molecular Imaging Wagner-Torizuka Fellowship 2023-2025
6 · The paper itself

Abstract

Rigidity, a cardinal symptom of Parkinson's disease (PD), remains challenging to assess objectively. A torque-angle instrument was developed to quantify muscle tone, providing two parameters: bias difference and elastic coefficient. This study aimed to investigate the association of the instrument-measured rigidity with clinical assessments and brain function. In 30 patients with PD, the muscle tone in both arms was evaluated. Ten with wearing-off phenomenon were assessed twice, off and on condition. Twentynine patients underwent brain perfusion single-photon emission computed tomography (SPECT), and expression of PD-related covariance pattern (PDRP) was computed. Bias difference and elastic coefficient showed positive correlations with physician-rated rigidity (P < 0.002). Bias difference decreased after dopaminergic medication (P = 0.022) and was associated with lower body mass index (P = 0.012). Elastic coefficient positively correlated with the Unified PD Rating Scale Part III and PDRP scores (P < 0.044). Furthermore, the higher bias difference correlated with decreased sensory-motor cortex and increased substantia nigra perfusion (P < 0.001). The Torque-angle instrument is a viable tool for quantifying rigidity in PD. The bias difference reflects treatment responsiveness and is associated with the function in the sensory-motor cortex and substantia nigra. The elastic coefficient is indicative of overall Parkinsonism severity.

Indexed as

BrainMuscle RigidityParkinson DiseaseAgedFemaleHumansMaleMiddle AgedTomography, Emission-Computed, Single-PhotonBrain perfusionNetwork analysisParkinson’s diseaseRigiditySingle photon emission tomography (SPECT)Torque-angle measurement

Identifiers

PMID40055432
PMCPMC11889231

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.